Fig. 2: The CPT score predicts chemotherapeutic response in MIBC. | British Journal of Cancer

Fig. 2: The CPT score predicts chemotherapeutic response in MIBC.

From: Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients

Fig. 2

a Kaplan–Meier analysis for OS stratified by CD39+ cells infiltration and ACT application in ZSHS cohort. Log-rank test was performed. b PD-L1, TMB and CD39 expression influenced response to platinum-based chemotherapy in TCGA cohort. c Kaplan–Meier analysis demonstrated the overall survival probability stratified by the CPT score in patients with platinum-based chemotherapy or without platinum-based chemotherapy. Log-rank test was performed. d Clinical response to platinum-based chemotherapy by CPT score in TCGA cohort. Chi-square test was performed (**P < 0.01). ACT adjuvant chemotherapy.

Back to article page